Number Needed to Treat with Vertebral Augmentation to Save a Life

References

1. 1.↵
   1. Jha RM,
   2. Yoo AJ,
   3. Hirsch AE, et al

   . Predictors of successful palliation of compression fractures with vertebral augmentation: single-center experience of 525 cases. J Vasc Interv Radiol 2009;20:760–68 doi:10.1016/j.jvir.2009.01.037 pmid:19465306

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Wardlaw D,
   2. Cummings SR,
   3. Van Meirhaeghe J, et al

   . Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet 2009;373:1016–24 doi:10.1016/S0140-6736(09)60010-6 pmid:19246088

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Klazen CA,
   2. Lohle PN,
   3. de Vries J, et al

   . Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (VERTOS II): an open-label randomised trial. Lancet 2010;376:1085–92 doi:10.1016/S0140-6736(10)60954-3 pmid:20701962

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Kallmes DF,
   2. Comstock BA,
   3. Heagerty PJ, et al

   . A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med 2009;361:569–79 doi:10.1056/NEJMoa0900563 pmid:19657122

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Buchbinder R,
   2. Osborne RH,
   3. Ebeling PR, et al

   . A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med 2009;361:557–68 doi:10.1056/NEJMoa0900429 pmid:19657121

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Hirsch JA,
   2. Chandra RV,
   3. Pampati V, et al

   . Analysis of vertebral augmentation practice patterns: a 2016 update. J Neurointerv Surg 2016;8:1299–1304 doi:10.1136/neurintsurg-2016-012767 pmid:27799375

   Abstract/FREE Full Text
7. 7.↵
   1. Ong KL,
   2. Beall DP,
   3. Frohbergh M, et al

   . Were VCF patients at higher risk of mortality following the 2009 publication of the vertebroplasty “sham” trials? Osteoporos Int 2018;29:375–83 doi:10.1007/s00198-017-4281-z pmid:29063215

   CrossRefPubMed
8. 8.↵
   1. Clark W,
   2. Bird P,
   3. Gonski P, et al

   . Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2016;388:1408–16 doi:10.1016/S0140-6736(16)31341-1 pmid:27544377

   CrossRefPubMed
9. 9.↵
   1. Firanescu CE,
   2. Vries J,
   3. Lodder P, et al

   . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 2018;361:k1551 doi:10.1136/bmj.k1551 pmid:29743284

   Abstract/FREE Full Text
10. 10.↵
    1. Edidin AA,
    2. Ong KL,
    3. Lau E, et al

    . Mortality risk for operated and nonoperated vertebral fracture patients in the Medicare population. J Bone Miner Res 2011;26:1617–26 doi:10.1002/jbmr.353 pmid:21308780

    CrossRefPubMed
11. 11.↵
    1. Lange A,
    2. Kasperk C,
    3. Alvares L, et al

    . Survival and cost comparison of kyphoplasty and percutaneous vertebroplasty using German claims data. Spine (Phila Pa 1976) 2014;39:318–26 doi:10.1097/BRS.0000000000000135 pmid:24299715

    CrossRefPubMed
12. 12.↵
    1. Martinez-Gutierrez JC,
    2. Leslie-Mazwi T,
    3. Chandra RV, et al

    . Number needed to treat: a primer for neurointerventionalists. Interv Neuroradiol 2019;25:613–18 doi:10.1177/1591019919858733

    CrossRef
13. 13.↵
    1. Edidin AA,
    2. Ong KL,
    3. Lau E, et al

    . Morbidity and mortality after vertebral fractures: comparison of vertebral augmentation and nonoperative management in the Medicare population. Spine 2015;40:1228–41 doi:10.1097/BRS.0000000000000992 pmid:26020845

    CrossRefPubMed
14. 14.↵
    1. Altman DG,
    2. Andersen PK

    . Calculating the number needed to treat for trials where the outcome is time to an event. BMJ 1999;319:1492–95 doi:10.1136/bmj.319.7223.1492 pmid:10582940

    FREE Full Text
15. 15.↵
    1. Bowry SK,
    2. Schoder V,
    3. Apel C

    . An inadvertent but explicable error in calculating number needed to treat for reporting survival data. J Am Soc Nephrol 2014;25:875–76 doi:10.1681/ASN.2014020188 pmid:24722435

    FREE Full Text
16. 16.↵
    1. Babayev M,
    2. Lachmann E,
    3. Nagler W

    . The controversy surrounding sacral insufficiency fractures: to ambulate or not to ambulate? Am J Phys Med Rehabil 2000;79:404–09 doi:10.1097/00002060-200007000-00014 pmid:10892628

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Manchikanti L,
    2. Kaye AM,
    3. Knezevic NN, et al

    . Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician 2017;20:S3–92 pmid:28226332

    PubMed
18. 18.↵
    1. Manchikanti L,
    2. Boswell MV,
    3. Kaye AD, et al

    . Therapeutic role of placebo: evolution of a new paradigm in understanding research and clinical practice. Pain Physician 2017;20:363–86 pmid:28727700

    PubMed
19. 19.↵
    1. Manchikanti L,
    2. Knezevic NN,
    3. Boswell MV, et al

    . Epidural injections for lumbar radiculopathy and spinal stenosis: a comparative systematic review and meta-analysis. Pain Physician 2016;19:E365–10 pmid:27008296

    PubMed
20. 20.↵
    1. Kado DM,
    2. Huang MH,
    3. Karlamangla AS, et al

    . Hyperkyphotic posture predicts mortality in older community-dwelling men and women: a prospective study. J Am Geriatr Soc 2004;52:1662–67 doi:10.1111/j.1532-5415.2004.52458.x pmid:15450042

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Cook RJ,
    2. Sackett DL

    . The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995;310:452–54 doi:10.1136/bmj.310.6977.452 pmid:7873954

    FREE Full Text
22. 22.↵
    1. Hacke W,
    2. Kaste M,
    3. Bluhmki E, et al

    . Thrombolysis with alteplase 3 to 4.5 hours after acute ischaemic stroke (ECASS III). N Engl J Med 2008;359:1317–29 doi:10.1056/NEJMoa0804656 pmid:18815396

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Chou R,
    2. Dana T,
    3. Blazina I, et al

    . Statins for prevention of cardiovascular disease in adults: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2016;316:2008–24 doi:10.1001/jama.2015.15629 pmid:27838722

    CrossRefPubMed
24. 24.↵
    Antithrombotic Trialists Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;373:1849–60 doi:10.1016/S0140-6736(09)60503-1 pmid:19482214

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Stergiopoulos K,
    2. Boden WE,
    3. Hartigan P, et al

    . Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials. JAMA Intern Med 2014;174:232–40 doi:10.1001/jamainternmed.2013.12855 pmid:24296791

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Hirsch JA,
    2. Beall DP,
    3. Chambers MR, et al

    . Management of vertebral fragility fractures: a clinical care pathway developed by a multispecialty panel using the RAND/UCLA appropriateness method. Spine J 2018;18:2152–61 doi:10.1016/j.spinee.2018.07.025 pmid:30096377

    CrossRefPubMed
27. 27.↵
    1. Cianfoni A,
    2. Distefano D,
    3. Isalberti M, et al

    . Stent-screw-assisted internal fixation: the SAIF technique to augment severe osteoporotic and neoplastic vertebral body fractures. J Neurointerv Surg 2019;11:603–09 doi:10.1136/neurintsurg-2018-014481 pmid:30552168

    Abstract/FREE Full Text
28. 28.↵
    1. Shah LM,
    2. Jennings JW,
    3. Kirsch CF, et al

    . ACR appropriateness criteria management of vertebral compression fractures. J Am Coll Radiol 2018;15:S347–64 doi:10.1016/j.jacr.2018.09.019 pmid:30392604

    CrossRefPubMed
29. 29.↵
    1. Eberling PR,
    2. Akesson K,
    3. Bauer DC, et al

    . The efficacy and safety of vertebral augmentation: a second ASBMR Task Force Report. J Bone Miner Res 2019;34:3–21 doi:10.1002/jbmr.3653 pmid:30677181

    CrossRefPubMed